Population biology of malaria within the mosquito: density-dependent processes and potential implications for transmission-blocking interventions by Churcher, TS et al.
RESEARCH Open Access
Population biology of malaria within the
mosquito: density-dependent processes and
potential implications for transmission-blocking
interventions
Thomas S Churcher1*, Emma J Dawes1, Robert E Sinden2, George K Christophides2, Jacob C Koella3,
María-Gloria Basáñez1
Abstract
Background: The combined effects of multiple density-dependent, regulatory processes may have an important
impact on the growth and stability of a population. In a malaria model system, it has been shown that the
progression of Plasmodium berghei through Anopheles stephensi and the survival of the mosquito both depend
non-linearly on parasite density. These processes regulating the development of the malaria parasite within the
mosquito may influence the success of transmission-blocking interventions (TBIs) currently under development.
Methods: An individual-based stochastic mathematical model is used to investigate the combined impact of these
multiple regulatory processes and examine how TBIs, which target different parasite life-stages within the
mosquito, may influence overall parasite transmission.
Results: The best parasite molecular targets will vary between different epidemiological settings. Interventions that
reduce ookinete density beneath a threshold level are likely to have auxiliary benefits, as transmission would be
further reduced by density-dependent processes that restrict sporogonic development at low parasite densities.
TBIs which reduce parasite density but fail to clear the parasite could cause a modest increase in transmission by
increasing the number of infectious bites made by a mosquito during its lifetime whilst failing to sufficiently
reduce its infectivity. Interventions with a higher variance in efficacy will therefore tend to cause a greater
reduction in overall transmission than a TBI with a more uniform effectiveness. Care should be taken when
interpreting these results as parasite intensity values in natural parasite-vector combinations of human malaria are
likely to be significantly lower than those in this model system.
Conclusions: A greater understanding of the development of the malaria parasite within the mosquito is required
to fully evaluate the impact of TBIs. If parasite-induced vector mortality influenced the population dynamics of
Plasmodium species infecting humans in malaria endemic regions, it would be important to quantify the variability
and duration of TBI efficacy to ensure that community benefits of control measures are not overestimated.
Background
Density-dependent processes that regulate population
growth are common in host-parasite systems and can
influence the resilience of an infection to control inter-
ventions [1]. In a model malaria-mosquito system, the
progression of Plasmodium berghei through Anopheles
stephensi depends non-linearly on parasite density [2].
Two types of density dependence operate during spor-
ogony in this system. Firstly, the transitions from the
female (macro-)gametocyte to ookinete, ookinete to
oocyst, and oocyst to sporozoites are all restricted at
high parasite densities. These negative density-depen-
dent processes limit sporogony at high parasite densities
(when the per parasite rate of transition to the next
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stage tends to zero), but are relaxed as density
decreases. Secondly, an additional, positive density
dependence impedes the transformation from ookinete
to oocyst in mosquitoes with a low number of ookinetes
[2]. This mechanism (the Allee effect) initially facilitates
transmission as ookinete density increases, but will
make it unstable at low parasite densities.
In addition to this density-dependent sporogonic devel-
opment, the mosquito’s (and thus parasite’s) survival
could be influenced by parasite density. Indeed, there is
growing evidence that the mosquitoes survival depends
on its age [3,4] and that Plasmodium may influence the
life-expectancy of the mosquito [5] (although a meta-ana-
lysis of laboratory experiments investigating the effect of
the malaria parasite on mosquito survival yielded incon-
clusive results [6]). In these experiments, the mortality
rate of An. stephensi was dependent on its age and on the
presence and density of P. berghei [7]. These density-
dependent processes, identified in the P. berghei-An. ste-
phensi model system, may operate in other parasite-vec-
tor combinations [8,9], including those relevant to
human malaria [10-14]. Therefore, the interactions
between these different positive and negative density-
dependent processes may have important implications
for the control of human malaria.
The intensity of malaria transmission in endemic areas
is typically measured by the entomological inoculation
rate (EIR); the annual number of infectious bites
received by a person living in such areas. This metric
makes the assumption that the infectiousness of a mos-
quito is the same irrespective of how many sporozoites
are within the salivary glands. However, recent evidence
indicates that there is a correlation between the number
of P. berghei sporozoites at the bite site and the prob-
ability that the mouse host will go on to develop blood
infection [15]. The importance of parasite density as a
determinant of the potential for malaria transmission
from the vector to the human population would depend
on whether there is a correlation between the number
of sporozoites within the salivary glands, the number
injected into the human host, and ultimately the prob-
ability of acquiring the infection. Using quantitative
PCR, Medica & Sinnis [16] recently showed that there
was a statistically significant and positive correlation in
the Plasmodium yoelii-An. stephensi system, despite sub-
stantial variability in the number of sporozoites injected
between different mosquitoes and over time from the
same mosquito. Notwithstanding such a correlation, the
presence of parasite-induced, density-dependent vector
mortality would make parasite density important so
both sporozoite presence and density shall be presented
in this paper.
Density-dependent parasite growth may impact upon
various malaria control strategies. A number of
promising control measures are being developed with
the goal of reducing the incidence of human malaria by
blocking transmission to and from the mosquito vectors.
These include transmission-blocking vaccines (TBVs),
which target antigens expressed on the malaria parasite
within the mosquito [17], biological agents to prime the
mosquitoes’ immune system to reduce its infectivity
[18], and the use of refractory, genetically modified mos-
quitoes to reduce infection of the mosquito [19]. How-
ever, most of these transmission-blocking interventions
(TBIs) are, at present, only partially effective, so it is
important to understand how their interaction with the
non-linear processes taking place in the vector would
influence overall transmission. Potential vaccines under
investigation aim to target different Plasmodium life-
stages within the vector [20]. Understanding how the
population dynamics of the parasite within the mosquito
may enhance or hinder the impact of a TBI could guide
decisions as to which stage(s) to prioritize as target(s).
In this paper, mathematical models are used to inves-
tigate the potential effect on malaria transmission of the
multiple density-dependent processes that have been
identified in the P. berghei-An. stephensi model system.
Since deterministic models can underestimate the
cumulative effect of multiple non-linear functions, an
individual-based stochastic model is used to capture the
changes in parasite density over the different stages of
sporogonic development. The highly overdispersed dis-
tribution of parasites recorded among mosquitoes
[2,16,21-23] is also modelled explicitly, as parasite aggre-
gation will, on average, increase the influence of density-
dependent regulatory processes [24]. The results of the
model are used to re-fit the mortality data from mos-
quito experimental infections reported by Dawes et al
[7] to investigate how different parasite life-stages may
influence vector mortality (in [7] it was assumed that
the ookinete stage was responsible for excess mosquito
mortality). The full model is then used to investigate
how interventions targeting different within-vector para-
site life-stages would influence the transmission
dynamics of Plasmodium.
Methods
A stochastic individual-based model was used to calcu-
late the number of macrogametocytes, ookinetes,
oocysts and salivary gland sporozoites at different times
post-feeding in every mosquito of the hypothetical
population. To facilitate comparison with published data
the same post-feeding times are used as in [2], as these
represent typical time-points at which mosquitoes are
dissected to assess sporogonic development. Let Li
j
indicate the number of parasites of life-stage j within
mosquito i, be it macrogametocytes ingested ( Li
1 ) at
cessation of feeding, ookinetes at 15 hours ( Li
2 ), oocysts
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at day 10 ( Li
3 ), or sporozoites in the salivary glands at
day 21 ( Li
4 ). The life-expectancy of each mosquito was
then estimated from data in Dawes et al [7] and used to
quantify the contribution of each mosquito to overall
transmission. A graphical representation of the model
and the different density-dependent functions describing
sporogonic development are given in Figure 1. A full
description of the model and parameter values can be
found in Additional file 1.
Mosquito life-expectancy
It is unknown which stage(s) of Plasmodium develop-
ment cause(s) the excess mortality in the mosquito.
Ookinetes could increase susceptibility to bacterial
infection as they perforate the mosquito midgut [25],
whilst all three stages, ookinetes, oocysts, and sporo-
zoites, could cause physiological disruption [26], nutri-
ent depletion [26,27] or costly immune responses [28].
Assessing the parasite density in dead mosquitoes can
be difficult (unless a mosquito is dissected shortly after
its death, parasite counts are unreliable), so studies
investigating parasite-induced vector mortality typically
explore the association between mosquito mortality and
the estimated number of parasites ingested. If later spor-
ogonic stages cause mosquito mortality, any statistical
investigation must take into consideration the highly
non-linear relationship between the number of parasites
ingested and the number developing into the stage caus-
ing the mortality. Otherwise parasite-induced vector
mortality would be harder to detect. The relative success
of different TBIs will be influenced by which sporogonic
stage(s) cause(s) vector mortality. Therefore, scenarios
are investigated in which vector mortality is associated
with ookinete load; oocyst burden at day 10, or number
of salivary gland sporozoites at day 21 post-feeding by
re-fitting the empirical (parabolic) hazard function of [7]
to the mosquito mortality rate obtained by these authors
varying the life-stage that is responsible for the excess
mortality. The Akaike information criterion (AIC) was
used to distinguish between model fits (the best sup-
ported model being the one with the lowest AIC) [29].
Variability in intervention efficacy
If vector mortality were determined by parasite load and
not just parasite presence or absence, any variability in
intervention efficacy would influence its overall effec-
tiveness. Vaccinated populations typically generate a
wide range of antibody responses [30] and the efficacy
of other interventions may also vary. A partially effica-
cious intervention, which reduces parasite density but
fails to clear infection, may increase the life-expectancy
of a mosquito without substantially reducing its infectiv-
ity. This could lead to the intervention actually increas-
ing rather than decreasing overall transmission.
By way of illustration, the variability in efficacy of all
the interventions investigated in this paper was mod-
elled on the range of responses expected from a single
immunogenic TBV. Though the distribution of antibody
titres generated by any TBV is not well known, it is
expected to be similar to that in other human vaccines,
which tend to show a log-normal distribution of anti-
body concentrations [30,31]. The relationship between
Figure 1 Graphical description of the mathematical model describing sporogonic development within the mosquito prior to the
introduction of an intervention. The model charts the number of macrogametocytes, Li
1 , ookinetes, Li
2 , oocysts, Li
3 , and salivary gland
sporozoites, Li
4 , within mosquito i. For a full list of notation see Additional file 1. The graphs under each arrow indicate the density-dependent
processes describing the number of parasites which develop into the subsequent life-stage. Shaded areas indicate the 95% confidence intervals
for the best-fit model fitted in [2].
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antibody concentration and TBV efficacy is typically
highly non-linear (hyperbolic) and can be described
using the Hill equation [31] (see Protocol S1). This gen-
erates a skewed distribution of intervention efficacies
whose mean is always closer to 50% than the median (i.
e. a negative skew at high mean efficacies and a positive
skew at low mean efficacies). For comparability it was
assumed that all interventions reduce the production of
the specific life-stage at which they are targeted, and not
additionally the production of a subsequent stage. This
is analogous to TBV antibodies attacking surface pro-
teins of a particular life-stage as soon as they appear.
Lifetime mosquito contribution to transmission
To aid interpretation of the complex concepts investi-
gated in the paper, a measurement of parasite transmis-
sion is devised based on the contribution of an
individual mosquito to onwards transmission over its
lifetime (assuming that infection is acquired during its
first bloodmeal). This method of estimating the lifetime
transmission potential of a mosquito has been used in
other mathematical approaches, though the exact defini-
tions vary [32,33]. In this paper, the definition will
depend on whether it is assumed that the potential for
malaria transmission from vectors to humans is deter-
mined by the presence or the density of salivary gland
sporozoites. For the former, onwards transmission is
defined as “the mean number of infectious bites made
per mosquito during its lifetime”. For the latter, onwards
transmission is “the mean number of salivary gland
sporozoites available to be injected per mosquito during
its lifetime”. These metrics allow transmission to be
compared between mosquitoes that ingest different
gametocyte densities, irrespective of other contributing
factors such as the mosquito to human ratio, the human
blood index, and the endemicity of malaria.
Results
Cumulative impact of density-dependent sporogonic
development
The cumulative impact of the multiple density-depen-
dent processes acting on the progression of P. berghei
through the mosquito makes the relationship between
the number of macrogametocytes ingested and the pre-
sence or number of salivary gland sporozoites highly
non-linear (Figures 2A, D). In highly infected vertebrate
hosts, reducing the number of macrogametocytes
ingested by 50%, from 300,000 to 150,000, reduces spor-
ozoite prevalence by only ~6% and sporozoite density by
~24%. The number of vertebrate hosts with very high
gametocytaemia is likely to be relatively small as the
majority of infected individuals tend to have intermedi-
ate or low gametocyte densities (see [34], though care
should be taken when comparing gametocyte densities
between species as P. falciparum typically has higher
mosquito infectivity [35]). To illustrate the epidemiolo-
gical importance of vertebrate hosts with relatively low
gametocytaemia, all additional graphs have a logged x-
axis. Figures 2B and 2E show how TBIs targeting differ-
ent life-stages will influence the final presence and den-
sity of salivary gland sporozoites within the mosquito.
Precisely which parasite life-stage is best to target to
achieve the greatest reduction in transmission will
depend on intervention efficacy, number of gametocytes
ingested, and on whether malaria transmission intensity
is assumed to depend on the presence or the density of
salivary gland sporozoites (Figures 2C and 2F). Target-
ing the ookinete life-stage is the most successful strategy
when the intervention is highly efficacious or the mos-
quito ingests a low/intermediate number of parasites
(Figure 2C). This is because the Allee-effect (positive
density dependence) acts on the production of oocysts
at low ookinete densities (Figure 1). Reducing ookinete
density per mosquito beneath a certain threshold (212
in this model system) would enhance parasite control by
making the development of ookinetes to oocysts less
efficient, giving additional benefits to TBIs. An interven-
tion reducing ookinete density by 60% (blue line) in
mosquitoes ingesting less than 100,000 macrogameto-
cytes has a greater than 60% reduction in the density of
salivary gland sporozoites (Figure 2E).
Parasite life-stage causing vector mortality
The results of the above model were used to re-fit the
relationship between parasite density and mosquito
mortality rate using the same data and methodology
presented in [7] (see Additional file 1). The model that
used the number of salivary gland sporozoites as the
explanatory variable gave the best fit to the experimental
data (AIC = -3384), followed by oocysts (AIC = -3376)
and finally ookinetes (AIC = -3370). However, this result
should be interpreted with caution. Though the AIC
values were able to clearly distinguish between the mod-
els that used sporozoites or ookinetes as the explanatory
variable, the difference between the sporozoite and
oocyst models was not so great as to exclude either
model. The best-fit models were used to show the rela-
tionship between the number of gametocytes ingested
and the number of infectious bites made by a mosquito
during its lifetime (see Additional file 2).
The complex relationship between the aggregated para-
site distribution and the range of efficacies generated by a
potential TBV makes the impact of parasite-induced vec-
tor mortality far from intuitive. Ultimately, the impact of
parasite-induced vector mortality will depend on the
time it takes for an infected mosquito to become infec-
tious, the shape of the relationship between parasite den-
sity and mosquito mortality and the distribution of
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parasites within the population (both before and after an
intervention). If vector mortality is determined by the
number of oocysts, a mosquito that ingests 100,000
macrogametocytes will bite, on average, 21% fewer times
from 16 days after blood-feeding onwards (i.e., once it is
infectious, see Additional file 1) than an uninfected mos-
quito (a drop from 3.8 to 3.0). This figure drops to 13%
(from 3.8 to 3.3) if vector mortality is caused by the num-
ber of sporozoites within the salivary glands.
Overall transmission prior to intervention
The cumulative impact of density-dependent sporogonic
development and vector mortality on overall transmission
is shown in Figure 3. If the intensity of malaria transmission
were determined by parasite density, then the reduction in
the number of infectious bites at high parasite densities
would be offset by a net increase in the number of sporo-
zoites reaching the salivary glands. Therefore, in this sce-
nario the highest contribution to transmission would be
made by mosquitoes that ingest the greatest number of
gametocytes (Figures 3E and 3G). However, if malaria
transmission were determined solely by the number of
infectious bites, then increases in parasite density above a
certain threshold would have only a minimal impact on
mosquito infectivity. Mosquitoes that feed on hosts with
intermediate gametocytaemia densities could therefore
make the highest contribution to overall transmission. This
is seen in the absence of an intervention in Figure 3A, in
Figure 2 The impact of transmission-blocking interventions which target different parasite life-stages on the prevalence and density
of salivary gland sporozoites. The Figure shows the relationship between the number of macrogametocytes ingested and the mean
prevalence of infectious mosquitoes (dashed lines, A and B) or the mean number of salivary gland sporozoites per mosquito (solid lines, D and
E). The model (described in Protocol S1) was run with either no intervention (black line) or representing an intervention which reduced the
production of a Plasmodium life-stage by 60%: macrogametocytes (yellow line); ookinetes (blue line); oocysts (green line); salivary gland
sporozoites (red line). The grey dotted-dashed line in panel B and panel E (where it lies on top of the red line) indicates an overall reduction in
sporozoite density/prevalence of 60% as a benchmark for comparison. The shaded areas of panels A and D depict the 95% confidence intervals
for the best-fit model. Panel D illustrates the importance of using an individual-based model (with which to account for parasite aggregation), as
simply combining the three density-dependent functions within a mean-based, deterministic model (thin dotted-dashed line) underestimates
the severity of the non-linear relationship. Panels C and F show which is the best life-stage to target to reduce transmission for a range of
gametocyte densities and intervention efficacies: macrogametocytes (yellow surface); ookinetes (blue surface); sporozoites (red surface).
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which transmission peaks in mosquitoes that ingest
~100,000 macrogametocytes per bloodmeal, if vector mor-
tality is determined by oocyst density. However, if vector
mortality were determined by sporozoite density (Figure
3C), then the small increase in the prevalence of infectious
mosquitoes as the number of macrogametocytes rises
above 200,000 per bloodmeal is enough to counteract the
reduction in the mean number of infectious bites made by
the mosquito population during their lifetime. This is in
part because the highly aggregated distribution of parasites
within the vector population ensures that a high percentage
of the parasites are within heavily infected mosquitoes,
which will not survive long enough to contribute to trans-
mission. Re-running the model assuming that parasites are
Poisson-distributed within the mosquito population
increases the modal relationship between gametocytaemia
and transmission (see Additional file 3).
Overall transmission after an intervention
A TBI with low efficacy could elevate transmission
intensity above that seen prior to the intervention. For
example, if parasite-induced vector mortality were deter-
mined by oocyst density in the mosquito, then accord-
ing to the model, the maximal average number of
infectious bites during the lifetime of a mosquito prior
to an intervention would be 2.3. This could increase to
2.9 if a TBI reducing oocyst density by approximately
60% was introduced (Figure 3A). This is because mos-
quitoes that ingest a high number of gametocytes have a
greater chance of becoming infected, but a lower life
expectancy. If an intervention reduced the number of
parasites of the life-stage that causes vector mortality,
the life-expectancy of the mosquito would increase,
boosting transmission.
Again, the impact of TBIs that target different sporo-
gonic stages on the overall level of transmission will
depend on the efficacy of the intervention, the number
of gametocytes ingested by the mosquito and the biol-
ogy of the infection (Figure 3). The likelihood of an
intervention increasing transmission will depend on
which parasite life-stage the intervention is targeting
and which life-stage vector mortality is dependent on.
Figure 3 The impact on transmission of interventions which target different parasite life-stages. The Figure shows the relationship
between the number of macrogametocytes ingested and transmission according to whether the latter is dependent on the presence (dashed
lines, panels A, B, C and D) or density (solid lines, panels E, F, G and H) of salivary gland sporozoites. The mean number of infectious bites per
mosquito and the lifetime mean number of salivary gland sporozoites available to be injected per mosquito are both estimated assuming the
mosquito is infected at its first bloodmeal. Parasite-induced vector mortality is dependent on the number of oocysts at day 10 (A, B, E and F) or
salivary gland sporozoites on day 21 (C, D, G and H). In panels A, C, E and G the model was run with either no intervention (black line) or
representing an intervention which reduced the production of a life-stage by 60%: gametocytes (yellow line); ookinetes (blue line); oocysts
(green line); salivary gland sporozoites (red line). Note that the black and red lines overrun each other in panel A. The thin grey dotted-dashed
line indicates an overall efficacy of 60% for comparison. The contour plots (panels B, D, F and H) show the relationship between
gametocytaemia, the efficacy of an intervention which targeting oocysts and the overall reduction in transmission that this intervention causes.
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Interventions are less likely to have a negative effect in
mosquitoes which ingest a low number of gametocytes.
However, if vector mortality is caused by later sporogo-
nic stages then interventions with low efficacies which
target oocysts or sporozoites may have a perverse out-
come irrespective of how many gametocytes the mos-
quito ingests, though the size of the effect is likely to be
modest (Figures 3B and 3D).
Parasite-induced vector mortality will make the effec-
tiveness of an intervention depend on its ability to
reduce parasite prevalence as well as parasite density. A
partially effective intervention with a high variance in
efficacy will tend to cause a greater reduction in trans-
mission than one with a lower variance, as it will have a
the greatest chance of clearing infection in some mos-
quitoes whilst minimising the number of bites made by
those still contributing to transmission (Figure 4).
Discussion
Density-dependent processes regulating malaria parasite
development within the mosquito are likely to influence
the success of partially effective TBIs and should be
considered when making decisions on which stage(s) to
prioritize as target(s). The complex relationships
between different positive and negative density-depen-
dent processes mean that the life-stage that is best to
target may also vary between settings. However, some
general conclusions can be drawn from this analysis.
Interventions that reduce ookinete density beneath a
threshold are likely to have auxiliary benefits as they uti-
lize positive density-dependent processes naturally
restricting sporogonic development at low densities.
TBIs which fail to reduce ookinete density beneath this
threshold will have a lower overall impact on transmis-
sion than the efficacy achieved at the targeted life-stage.
Unless the intervention successfully clears the infection,
any reductions in parasite density could potentially
increase the life-expectancy of the mosquito, enhancing
transmission. Therefore partially effective interventions
with a high variance in effectiveness will be more effec-
tive than those that have a more uniform efficacy.
Model systems provide a powerful tool for identifying
testable hypotheses that may be applicable to the trans-
mission of human malaria. The processes investigated in
this paper have been identified and quantified in the P.
berghei-An. stephensi laboratory model and this work
needs to be repeated in naturally found parasite-vector
combinations to draw definitive conclusions about
human malaria. Similar density-dependent processes
influencing sporogonic development within the mos-
quito have been identified in other parasite-vector com-
binations [8,36]. Indeed, a number of studies of P.
falciparum indicate a sigmoidal relationship between
gametocyte density and mosquito infectivity [10-14],
indicating that positive and negative regulatory
Figure 4 The relationship between gametocytaemia and transmission for three different theoretical transmission blocking vaccines
which have the same mean efficacy but differ in their variance. The two panels show the impact of the interventions which reduce the
production of ookinetes by an average of 60% if malaria transmission is dependent on the presence (dashed line, panel A) or density (solid line,
pane B) of salivary gland sporozoites. Predictions are shown for no intervention (black line) or for a TBV which generates a range of antibody
responses in the vaccinated population corresponding to a ratio of the 97.5% percentile to the 2.5% percentile of 9 fold (low variance, light
green), 68 fold (medium variance, dark green) or 6664 fold (high variance, purple) [31].
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processes within the mosquito may influence the popu-
lation dynamics of human malaria.
This paper has examined the effect of different poten-
tial TBIs on mosquitoes fed on blood with known game-
tocyte concentrations. More accurate estimation of an
intervention’s impact at the population level will require
information on the distribution of gametocytes within
the bitten human population, and this is likely to vary
temporally [37], geographically [14], and with treatment
[38]. As a result, the community impact of different
TBIs will likely vary from setting to setting. Gametocyte
densities of Plasmodium falciparum are lower than
those in the experimental system investigated here, with
a significant proportion of human hosts having densities
too low to detect through standard microscopy [34].
This may improve the efficacy of TBIs if ookinete densi-
ties were low enough to restrict transmission as a conse-
quence of the positive density-dependent processes that
may operate on oocyst development.
The chance that a TBI actually increases the average
number of infectious bites a human host population is
exposed to will depend on the severity of parasite-
induced vector mortality, the distribution of parasites
within the human host and mosquito population before
and after the intervention, and the shape of the relation-
ship between gametocyte density and mosquito infectiv-
ity. The probability of infecting a feeding mosquito
plateaus at moderate gametocyte densities, though the
exact shape of this gametocytaemia-infectivity relation-
ship may vary [39-41]. Therefore, partially decreasing
gametocyte density in human hosts with high gametocy-
taemia may not substantially decrease the host’s ability
to infect a mosquito. In such a scenario, even weak den-
sity-dependent parasite-induced vector mortality would
reduce the number of infectious bites made by vectors
ingesting a high number of gametocytes. The conse-
quences of this for malaria transmission will depend on
the distribution of gametocytes within the human host
population. An intervention may reduce the contribu-
tion to transmission of hosts with low gametocytaemia
whilst at the same time increasing the number of infec-
tious bites made by mosquitoes (during their lifetime)
that feed on highly gametocytaemic hosts. The overall
change in the potential for malaria transmission will
therefore depend on whether the cumulative reduction
in transmission from human hosts with low number of
gametocytes outweighs the increase in transmission
caused by heavily infected hosts.
The model has been parameterized using mosquito
mortality data from laboratory experiments where the
insects will live much longer than they would do under
natural conditions. In the wild, mosquitoes are likely to
make relatively few bites more than 10 days after
becoming infected, so malaria transmission will be
highly sensitive to small changes in mosquito mortality.
In addition, older mosquitoes are much more suscepti-
ble to changes in parasite density [7]. Since these are
the mosquitoes contributing most to transmission (given
the long extrinsic incubation period of Plasmodium
within Anopheles) even a small increase in mortality of
this age group may have a significant impact on
transmission.
The results of this analysis indicate that interventions
with an intermediate or low efficacy are more likely to
cause an increase in transmission. Although it is unlikely
that any TBI with a low efficacy would be deployed in a
public health programme, the effectiveness of an inter-
vention may wane over time so it is important to con-
sider how these low efficacies will influence transmission
dynamics. For example, TBV efficacy may decline rela-
tively rapidly as the concentration of antibodies within
the bloodstream falls. This means that unless vaccine effi-
cacy is regularly boosted, antibody concentration may
drop, causing the level of transmission to increase above
pre-intervention levels. This is in additions to any
enhancement of mosquito infectivity that may occur as
the concentration of serum antibodies falls [42-44].
It is interesting to note that if parasite-induced vector
mortality operates in natural combinations of medical
importance, then Plasmodium may benefit from eliciting
a mild transmission-blocking immune response. If
malaria transmission is determined by sporozoite pre-
sence (rather than density), then reducing parasite den-
sity once the mosquito is infected will tend to increase
overall transmission by reducing the mortality of the
insect vector. Pre-fertilization antigens are known to be
a target of the natural immune response and it may be
more plausible to ascribe this type of immunity to an
evolutionary response by the parasite and not the
human host.
Further work is required to identify whether parasite-
induced vector mortality acts in malaria endemic
regions so that any perverse outcome of TBIs can be
thoroughly understood and contained. Taking into
account the possible non-linear relationships between
different sporogonic life-stages will increase the chance
of identifying any changes in mosquito mortality caused
by the parasite. Re-fitting vector mortality data indicates
that later sporogonic stages are the most likely cause of
parasite-induced vector mortality. However, it is likely
that more than one parasite life-stage will play a role, as
oocysts or sporozoites cannot have caused the elevated
mortality seen in mosquitoes immediately after blood
feeding.
Research into possible TBIs should consider how the
development of the parasite within the mosquito may
influence study results. The standard method of asses-
sing the efficacy of a TBV is to compare the number of
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oocysts within mosquitoes fed on immunised/unimmu-
nised blood [45,46]. These efficacy estimates therefore
already include the net effects of all density-dependent
mechanisms acting upon the production of ookinetes
and oocysts. Interventions targeting gametocytes and
ookinetes may have had a different efficacy than that
measured at the oocyst stage, depending on the number
of gametocytes ingested. Understanding this may
improve the accuracy of molecular methods for asses-
sing TBV efficacy [46]. Researchers should also be aware
that reductions in oocyst intensity may overestimate
reductions in malaria transmission due to the actions of
density-dependent sporozoite development and parasite-
induced vector mortality.
In light of the possible impact of parasite-induced vec-
tor mortality, lab-based studies measuring intervention
efficacy should compare the survival of mosquitoes
between treatment groups over their whole lifetime.
This is because vectors that ingest a lower number of
parasites may have had a higher probability of surviving
long enough to be dissected. Failing to control for this
may cause the intervention efficacy to be overestimated.
It is also important to investigate the impact of an inter-
vention on the survival of older mosquitoes as they
make the greatest contribution to overall transmission.
Studies should quantify the distribution of efficacies
caused by a TBI (both within the human host and the
mosquito) to allow the full impact of a control measure
to be estimated. It is also important to understand how
the efficacy of an intervention may change over time.
Phase II clinical trials of possible TBV candidates should
quantify the rate and variance of antibody decay in a
range of environmental settings (i.e. with different
degrees of natural immunological boosting from
ongoing infection). In addition, ideally the duration of
both Phase II and Phase III trials should be lengthened
until target antibody concentrations have returned to
pre-intervention levels, allowing the full impact of start-
ing an intervention but failing to sustain it to be
quantified.
There is evidence that other regulatory processes act-
ing upon the malaria parasite within the mosquito may
also be density-dependent in natural populations. For
example, Plasmodium may influence mosquito biting
frequency [47], feeding persistence [48] and physiology
[49]. Other factors such as parasite sex ratio may also
affect the likelihood of onwards transmission [50], and
therefore should be considered when quantifying the
overall impact of an intervention. Similar methods
should be used to understand the influence of multiple
density-dependent processes on other vector-borne dis-
eases as parasite development and vector survival have
been shown to be influenced by the parasite density in
both human onchocerciasis [51,52] and lymphatic filar-
iasis [53-55].
Conclusions
This paper has highlighted the importance of understand-
ing the population dynamics of the malaria parasite within
the mosquito as processes regulating the development of
the parasite may enhance or impede the effectiveness of a
control strategy. Mathematical models should be used to
investigate how an intervention influences both parasite
development and vector mortality in order to fully evalu-
ate the effectiveness of the new transmission blocking
interventions currently under development.
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